UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3756) 3756
Newspaper Article (104) 104
Newsletter (69) 69
Book Chapter (49) 49
Magazine Article (35) 35
Book / eBook (5) 5
Dissertation (4) 4
Conference Proceeding (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2646) 2646
science & technology (2615) 2615
life sciences & biomedicine (2523) 2523
animals (2037) 2037
male (1569) 1569
female (1248) 1248
venom (1215) 1215
adult (891) 891
middle aged (849) 849
biological and medical sciences (722) 722
medical sciences (678) 678
immunology (539) 539
diabetes mellitus, type 2 - drug therapy (510) 510
allergy (488) 488
venoms - therapeutic use (481) 481
aged (475) 475
toxicology (465) 465
peptides - therapeutic use (455) 455
abridged index medicus (423) 423
adolescent (406) 406
treatment outcome (396) 396
hypoglycemic agents - therapeutic use (392) 392
venoms - adverse effects (371) 371
antivenins - therapeutic use (368) 368
pharmacology & pharmacy (366) 366
exenatide (362) 362
mice (352) 352
child (349) 349
research (344) 344
care and treatment (337) 337
bites and stings (332) 332
immunotherapy (325) 325
snakes (317) 317
peptides - adverse effects (316) 316
type 2 diabetes (308) 308
venoms - administration & dosage (299) 299
endocrinology & metabolism (295) 295
peptides - administration & dosage (291) 291
diabetes (277) 277
general & internal medicine (272) 272
health aspects (269) 269
hypoglycemic agents - adverse effects (269) 269
analysis (266) 266
medicine, general & internal (251) 251
snake bites - therapy (250) 250
hypoglycemic agents - administration & dosage (248) 248
bee venoms - adverse effects (246) 246
peptides (245) 245
peptides - pharmacology (240) 240
medicine (232) 232
risk factors (229) 229
anaphylaxis (227) 227
rats (209) 209
time factors (208) 208
venoms - pharmacology (203) 203
insect bites and stings - immunology (201) 201
allergies (199) 199
studies (193) 193
antivenom (191) 191
bees (188) 188
child, preschool (186) 186
young adult (186) 186
anaphylaxis - etiology (185) 185
drug therapy (184) 184
antivenins - adverse effects (178) 178
retrospective studies (178) 178
bee venoms - immunology (175) 175
proteins (174) 174
snake bites - complications (170) 170
diabetes mellitus, type 2 - blood (168) 168
patients (168) 168
fundamental and applied biological sciences. psychology (166) 166
wasp venoms - adverse effects (166) 166
clinical trials (164) 164
insect bites and stings - complications (163) 163
research article (163) 163
animal poisons toxicology. antivenoms (162) 162
drug administration schedule (161) 161
dose-response relationship, drug (159) 159
glucagon-like peptide 1 - analogs & derivatives (158) 158
liraglutide (151) 151
biochemistry & molecular biology (150) 150
internal medicine (145) 145
medical research (145) 145
complex mixtures (142) 142
snake bites (141) 141
immunopathology (139) 139
drug therapy, combination (133) 133
hypoglycemic agents (131) 131
allergens - immunology (130) 130
toxins (130) 130
glucose (127) 127
insulin (127) 127
snake bites - drug therapy (127) 127
arthropod venoms - adverse effects (125) 125
blood glucose - drug effects (125) 125
blood glucose - metabolism (125) 125
glucagon-like peptide 1 - therapeutic use (125) 125
hymenoptera (125) 125
endocrinopathies (123) 123
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3800) 3800
French (68) 68
German (58) 58
Portuguese (39) 39
Polish (22) 22
Spanish (22) 22
Japanese (19) 19
Russian (13) 13
Chinese (11) 11
Korean (8) 8
Danish (7) 7
Swedish (7) 7
Norwegian (6) 6
Dutch (5) 5
Italian (5) 5
Turkish (3) 3
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes care, ISSN 0149-5992, 2014, Volume 37, Issue 8, pp. 2159 - 2167
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 03/2019, Volume 143, Issue 3, pp. 880 - 893
Journal Article
Journal Article
Diabetes care, ISSN 0149-5992, 10/2014, Volume 37, Issue 10, pp. 2763 - 2773
Journal Article
Pharmacology, ISSN 0031-7012, 08/2010, Volume 86, Issue 1, pp. 44 - 57
Review | Glycemic control | Diabetes | Incretin mimetics | Hypoglycemia | Dipeptyl peptidase type 4 inhibitor | Weight | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Triazoles - adverse effects | Nitriles - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Pyrrolidines - adverse effects | Pyrazines - therapeutic use | Weight Loss - drug effects | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Adamantane - therapeutic use | Adult | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Adamantane - pharmacology | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glucagon-Like Peptide 1 - pharmacology | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Triazoles - pharmacology | Pyrazines - adverse effects | Venoms - therapeutic use | Venoms - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Nitriles - adverse effects | Pyrazines - pharmacology | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Nitriles - therapeutic use | Index Medicus
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents | Index Medicus | Abridged Index Medicus
Journal Article